New Clinical Trials for Skin Cancer

Protection against skin cancer is importantWhile a lot is known about the causes of skin cancer, there is a lot to be learned about better ways to treat the disease. More skin cancer clinical studies are needed to develop advanced and sophisticated preventative methods.

There are new skin cancer clinical trials being conducted. If you have been diagnosed with skin cancer and would like to participate in a clinical trial please review the list. Participation in clinical trials is always at no cost to you.

What is Skin Cancer?

Skin cancer is cancer growths that form on the outside layer of the skin. The three most common malignant skin cancers are basal, squammous and melanoma. Since skin cancer develops on the skin it is generally easy to notice and diagnose. Tumors are highly visible in skin cancer. It is the most commonly diagnosed form of cancer and is generally very treatable. Most skin cancer is caused by prolonged exposure to the sun. Sunscreen can help, but it does not help with all types of cancer. Smoking can also cause skin cancer. Patients may first notice a change in skin color and texture and sometimes changes in the appearance of moles indicates that skin cancer is present. It is also known as skin neoplasm. Learn more by visiting the Skin Cancer Foundation.

Skin Cancer Treatments

The best way to treat skin cancer is to prevent it. Limiting exposure to the sun, especially during the peak hours of 10 a.m. – 3 p.m., wearing protective clothing and using sunscreen will all reduce the risk of developing skin cancer. Once developed the skin cancer treatment depends on the type, location, severity, and cause of the skin cancer. Low risk skin cancer treatments include radiation therapy, topical chemotherapy or cryotherapy (freezing off the cancer). There is also a surgery called Moh’s micrographic surgery that is sometimes used to remove the cancer.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,847 Skin Cancer
clinical trials

Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
Eligibility Screening and Tissue Procurement for the NIH Intramural Research Program Clinical Protocols
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 2/6/2009
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
Status: Enrolling
Updated: 12/17/2013
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
Status: Enrolling
Updated: 12/17/2013
mi
from
Providence, RI
Click here to add this to my saved trials
Oncology Clinical Trial
Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling
Updated: 9/19/2012
mi
from
New York, NY
Click here to add this to my saved trials
Intraocular Melanoma Clinical Trial
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Status: Enrolling, Phase II
Updated: 1/9/2014
mi
from
Encinitas, CA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase I, II
Updated: 1/9/2014
mi
from
Encinitas, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Status: Enrolling, Phase I, II
Updated: 10/16/2010
mi
from
Newark, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Stanford, CA
Click here to add this to my saved trials
Skin Cancer Clinical Trial
In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 9/19/2012
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acromegaly Clinical Trial
Lanreotide Levels in Acromegaly
Status: Enrolling
Updated: 6/9/2009
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Acromegaly Clinical Trial
Peri- and Post-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma
Status: Enrolling
Updated: 11/13/2012
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology, Reproductive Clinical Trial
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Status: Enrolling
Updated: 11/15/2012
mi
from
Boston, MA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
Status: Enrolling
Updated: 2/16/2016
mi
from
Cleveland, OH
Click here to add this to my saved trials
Stage IV Resectable Melanoma Clinical Trial
Stage IV Surgery Versus Best Medical Therapy
Status: Enrolling
Updated: 8/13/2012
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Stage IV Resectable Melanoma Clinical Trial
Stage IV Surgery Versus Best Medical Therapy
Status: Enrolling
Updated: 8/13/2012
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Electronic Brachytherapy for the Treatment of NMSC
Status: Enrolling
Updated: 7/17/2015
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Oncology, Orthopedics / Podiatry Clinical Trial
Evaluation and Treatment of Patients With Dermatologic Diseases
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Oncology Clinical Trial
Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.
Status: Enrolling
Updated: 1/12/2018
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
RO4929097 And Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer
Status: Enrolling
Updated: 1/14/2013
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib
Status: Enrolling
Updated: 3/11/2013
mi
from
Atlanta, GA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
Status: Enrolling
Updated: 12/16/2012
mi
from
Atlanta, GA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
South Pasadena, CA
Click here to add this to my saved trials
Melanoma Clinical Trial
Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma
Status: Enrolling
Updated: 6/25/2013
mi
from
Boston, MA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
La Jolla, CA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
Lebanon, NH
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Status: Enrolling
Updated: 6/24/2013
mi
from
Morristown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Dinaciclib in Treating Patients With Advanced Melanoma
Status: Enrolling
Updated: 1/15/2013
mi
from
Boston, MA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma
Status: Enrolling, Phase III
Updated: 1/6/2016
mi
from
Hershey, PA
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Franklin, WI
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Maywood, IL
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Tuscon, AZ
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
JAK2 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Oncology Clinical Trial
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Melanoma Clinical Trial
Tissue Procurement Substudy for Participants in Study CP-MGA271-01
Status: Enrolling, Phase I
Updated: 7/16/2015
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
mi
from
St. Louis, MO
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
mi
from
Birmingham, AL
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
mi
from
Chicago, IL
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
mi
from
Columbus, OH
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
mi
from
Nashville, TN
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
mi
from
New York, NY
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
mi
from
Peoria, AZ
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
mi
from
Washington DC,
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.
Status: Enrolling, Phase I, II
Updated: 4/16/2014
mi
from
Spokane, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Brookfield, WI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Davenport, IA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Lewiston, ME
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Lincoln, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Palm Coast, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Scottsbluff, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Westminster, MD
Click here to add this to my saved trials
Oncology Clinical Trial
CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotherapy Study for Patients With Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 10/28/2015
mi
from
Knoxville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotherapy Study for Patients With Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 10/28/2015
mi
from
Niles, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
Status: Enrolling, Phase I
Updated: 6/22/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Rochester, MN
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
Abraxane Plus Bevacizumab Versus Ipilimumab as 1st Line Therapy for BRAFwt Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 5/21/2014
mi
from
Buffalo, NY
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
Abraxane Plus Bevacizumab Versus Ipilimumab as 1st Line Therapy for BRAFwt Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 5/21/2014
mi
from
Green Bay, WI
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
Abraxane Plus Bevacizumab Versus Ipilimumab as 1st Line Therapy for BRAFwt Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 5/21/2014
mi
from
Omaha, NE
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
Abraxane Plus Bevacizumab Versus Ipilimumab as 1st Line Therapy for BRAFwt Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 5/21/2014
mi
from
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Anacortes, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bainbridge Island, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Baldwin Park, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bend, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boone, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boulder, CO
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 68